South Korea · Delayed Price · Currency is KRW Seegene Company Description
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide.
It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products.
The company also provides other products for the detection of six SNPs in factor II, factor V, and MTHFR genes; BRAF mutation characteristic for papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy, H&E slides, and paraffin-embedded tissues; Apolipoprotein E genotypes; and BCR/ABL fusion gene from blood and whole bone marrow.
In addition, it offers PCR machines; vial cap management systems; nucleic acid extraction systems; automated liquid handling workstations from nucleic acid extraction to PCR setup; and real-time PCR detection systems.
Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2000 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| CEO | Jong-Yoon Chun |
Contact Details
Address: Taewon Building Seoul South Korea | |
| Phone | 82 2 2240 4000 |
Stock Details
| Ticker Symbol | 096530 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7096530001 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Jong-Yoon Chun | Chief Executive Officer |